Skip to main content

Military Health System

WRNMMC’s participation in APOLLO program furthers cancer research

Image of Two groups of vials on a table. Vials containing DNA samples from studies of the genetic risk for cancer at the Cancer Genomics Research Laboratory, part of the National Cancer Institute's Division of Cancer Epidemiology and Genetics. (Photo by Daniel Sone, National Cancer Institute.)

Recommended Content:

Research and Innovation | Health Readiness & Combat Support

As cancer survivors, oncologist, researchers, providers and family members celebrated World Cancer Day today, the researchers, providers and support staff at the John P. Murtha Cancer Center (MCC) at Walter Reed National Military Medical Center in Bethesda, Maryland remain focused on the studying not only the effects of the deadly disease, but also best possible treatment options.

The MCC serves as the preeminent cancer research and treatment facility within the Department of Defense (DOD), and has been since the 1990s. In 2012, the center was renamed after Congressman John P. Murtha, a 30 year Marine Corps veteran and long-time advocate for cancer research within the Department of Defense.

The current Director of MCC and its Research Program, Dr. Craig Shriver, is focused on the threat cancer poses on the readiness of the United States Armed Forces. According to Shriver, there are more than 1,000 active duty service members diagnoses with cancer each year, and there are more than 8,000 active duty service members living with a cancer diagnosis. Researchers at the MCC are keenly interested in how cancer affects younger people, since most active duty service members are under the age of 35, Shriver explained.

To combat the effect cancer has on the readiness of the DOD’s mission, MCC has done research into the genetic causes of cancer. According to Shriver, MCC centers have been sequencing the genome of tumors for different cancer since the 1990s. According to Shriver, since the DOD has a disproportionately high number of African American’s compared to the general U.S. population, sequencing of tumors from African Americans with prostate cancer has shown certain genetic risk factors that had not been found previously. “This is research that not only benefits African American service members, but people of African descent worldwide,” says Shriver.

Currently the MCC is using genetic sequencing as part of its participation in the APOLLO (Applied Proeogenomics Organizational Learning Outcomes) research program. According to the National Cancer Institutes’ webpage, APOLLO is part of the Cancer Moonshot initiative, a tri-federal research program that began in 2016 under the leadership of then Vice President Joe Biden. APOLLO brings together the DOD through MCC, the departments of Veterans Affairs; and the department of Health and Human Services through the NCI. According to Shriver the three agencies work together in sharing research and information, as well as publishing the results of the program.

A group of medical researchers in a line, sitting down in front of monitors
Researchers at the John P. Murtha Cancer Center at WRNMMC study the genetic makeup of cancer cells. As part of the APOLLO research program, the Murtha Cancer Center is undergoing studies related to the genetics found in the tumors of cancer patients. The genetic sequencing of these tumors is leading to new discoveries in the treatment of cancer within active duty service members in the DOD. (Photo courtesy of Walter Reed National Military Medical Center.)

APOLLO studies the genetic components of tumors from cancer patients. According to Shriver, every newly diagnoses cancer patient in on of the Murtha facilities are given the option to join the research program. If a patient opts in, their tumor is run through all available molecular platforms looking at its DNA, RNA, and Protein structure.

According to NCI, the data from the APOLLO program will be “curated and made available publicly through the Genomic Data CommonsProteomic Data Portal, and Cancer Imaging Archive.  Using all of the data available (analytical, invasive, noninvasive, and clinical) will enable researchers to study the relationships among these data, validate results, and develop predictive and prognostic models to improve patient care.”

According to Shriver APOLLO uses precision oncology where researchers look to see if there are any special molecular signatures of an individual’s cancer that be targeted with available drugs. Shriver says that tumors of the same cancer type can have different genetic attributes, which might require different treatments. “We don’t treat every patient with colon cancer the same. You identify any unique aspects of the tumor and say, ‘okay this tumor is special in this way, we identified it through the molecular signature found in the APOLLO program’, and we treat it that way,” said Shriver.

After sequencing the genetic makeup of their tumor, a patient’s blood is then sequenced to find the DNA unique to that person. According to Shriver, many young people with cancer have a genetic germline mutation that could cause cancer. And there are 50 different genes that can lead, in isolation or combined, to an increased risk of cancers.

The APOLLO program also shares any information from their research back with the patient. “We have a very unique, almost unprecedented, genetic return of results program,” Shriver said adding “If we identify that service member X has a germline genetic mutation that could affect them, and their children, for increased cancer risk, we tell the patient that. This is unusual for a research program.”

Shriver says that this information sharing is called translational research. The gap between clinical care and research is translated and provides real benefits to patients and their providers through the genome sequencing of the patient’s blood.

The research from the APOLLO program is already starting to have real benefits to not only the DOD, but the United States population at large. According to Shriver, researchers in the program identified a new genetic signature that can distinguish between patients with lung cancer who will do well with a specific treatment from those who may not do well with said treatment. “If 20% of the population don’t do well for conventional treatment, and by sequencing the genetic of the tumor, we can find those patients and move forward with more unique options,” said Shriver.

The signature is intellectual property, and as such a patent is being filed so that it can be commercialized, and a test can go to the market. Lung cancer patients can take the panel test and providers can predict if they will do well with treatment or should try something else.

While the APOLLO program is beneficial for a more hidden side of the causes of cancer, Shriver still encourages known preventative measure should be taken by all active duty service members. Shriver says that avoiding or quitting use of tobacco and nicotine products are a good common knowledge practice.

According to Director of Gynecologic Oncology at WRNMMC, Air Force Col. (Dr.) Yovanni Casablanca, all service members regardless of gender should get the human papilloma virus, or HPV, vaccine which protects against cervical cancer.

Shriver believes genetic sequencing can be helpful to the DOD’s mission in the future outside of cancer research. According to Shriver, genetic sequencing could be utilized at military intake alongside other medical tests, to determine an individual’s genetic risk to certain cancers. “This wouldn’t be us turning someone away based on their sequencing. Instead we can use this information to help a service member who may be higher risk be aware and take proactive steps to mitigate the potential onset of certain cancers,” said Shriver.

For more information about the Murtha Cancer Center, or the APOLLO program, check their websites.

You also may be interested in...

Military Health Symposium Research Shapes Future of Warfighter Health

Article
10/5/2022
U.S. Army Col Jennifer Stowe presents her research from behind a podium at the MHSRS meeting 2022.

Scientific session at the Military Health System Research Symposium highlights research addressing critical military medical issues.

Recommended Content:

Research and Innovation | MHS Research Symposium

Cutting-Edge Science Featured at Military Health System Research Symposium

Article
9/15/2022
Ms. Seileen Mullen, the acting assistant secretary of defense for health affairs, makes opening remarks during the Military Health System Research Symposium at the Gaylord Hotel in Kissimmee, FL on Monday, September 12, 2022. MHSRS provides a collaborative setting for the exchange of information between military providers with deployment experience, research and academic scientists, international partners, and industry on research and related health care initiatives, such as Combat Casualty Care, Operational Medicine, Clinical and Rehabilitative Medicine, Medical Simulation and Information Sciences, and infectious Diseases.

The 2022 Military Health System Research Symposium, held in Kissimmee, Fla., opened this week after a two-year pandemic hiatus. The audience was enthusiastic as MHS leaders shared their opening remarks.

Recommended Content:

Research and Innovation | MHS Research Symposium

Research Symposium Recognizes 2022 Award Winners

Article
9/15/2022
Dr. Sumil Shah accepts the Outstanding Program Management (Team) Award, along with some members of his team from Ms. Seileen Mullen, the acting secretary of Defense for Health Affairs. MHSRS provides a collaborative setting for the exchange of information between military providers with deployment experience, research and academic scientists, international partners, and industry on research and related health care initiatives, such as Combat Casualty Care, Operational Medicine, Clinical and Rehabilitative Medicine, Medical Simulation and Information Sciences, and infectious Diseases.

The 2022 Military Health System Research Symposium highlighted and honored innovative researchers dedicated to help the warfighter on and off the battlefield.

Recommended Content:

Research and Innovation | MHS Research Symposium

Bulgarian Armed Forces Demonstrate Combat Medical Advancements

Article
8/22/2022
Two medics tend to a dummy in a simulated emergency.

Bulgarian Armed Forces showed off their combat lifesaving training to a U.S. delegation Aug. 10.

Recommended Content:

Education & Training | Health Readiness & Combat Support | Global Health Engagement

DHA Program Supports Training Education of Future Medical Providers

Article
7/20/2022
Military personnel looking at display

The Clinical Investigations Program combines research and training to teach and develop the future clinicians of the Military Health System.

Recommended Content:

Health Readiness & Combat Support | Education & Training | Health Care Technology | Health Readiness & Combat Support

The Need for Speed Requires Intense Training

Article
7/18/2022
 Military personnel conducts routine ops in US 3rd Fleet

Tom Cruise has nothing on real military pilots and their training.

Recommended Content:

Health Readiness & Combat Support | Education & Training | Physical Fitness

Army Experts: Rabies Risk is Not Worth It

Article
7/5/2022
Army Experts: Rabies Risk is Not Worth It

Almost 60,000 people around the world die from rabies each year. Despite the common belief that rabid animals are easily identified by foaming at the mouth and aggressive behavior, infected animals may not look sick or act strangely.

Recommended Content:

Health Readiness & Combat Support | Public Health | Rabies

Final Days in Afghanistan: Lab Techs Stepped Up to Support Withdrawal

Article
6/30/2022
Final Days in Afghanistan Lab Techs Stepped Up to Support Withdrawal

“Prior to the attack, teams were preparing to leave the area. Suddenly, everything changed, and our main goal shifted from COVID-19 support to blood supply and triage.”

Recommended Content:

Health Readiness & Combat Support

How Drones Will Transform Battlefield Medicine – and Save Lives

Article
6/23/2022
Drones carrying fresh blood products to wounded troops on the front lines may be critical for military medicine in a conflict against a "near-peer" adversary.

Emerging technology may use drones to deliver blood products for wounded troops on the front lines of combat. That capability may be critical in a "near-peer" conflict.

Recommended Content:

Health Readiness & Combat Support

How MHS GENESIS will become essential to patients' health journey

Article
6/21/2022
Dr. Robert Marshall, program director of the Department of Defense Clinical Informatics Fellowship at Madigan Army Medical Center.

Ensuring proper training of both providers and patients is essential for the successful integration and sustainment of MHS GENESIS into MHS care.

Recommended Content:

Health Readiness & Combat Support | Health Care Technology | MHS GENESIS Toolkit | MHS GENESIS: The Electronic Health Record | MHS GENESIS

How Military Medicine Is Preparing for the Next Conflict

Article
6/8/2022
As the Pentagon prepares today’s force for a “near-peer” fight against a large military adversary, the Military Health System is challenged to provide life-saving support for large-scale and dispersed operations.

As the Pentagon prepares today’s force for a “near-peer” fight against a large military adversary, the Military Health System is challenged to provide life-saving support for large-scale and dispersed operations. That’s especially true for the medics supporting troops on the front lines.

Recommended Content:

Health Readiness & Combat Support | Health Care Technology | Education & Training | Medical Education and Training Campus

Army Doctor Earns Top Honors at Air Assault School at Fort Campbell

Article
6/3/2022
Army Doctor Earns Top Honors at Air Assault School at Fort Campbell

This Army doctor finished at the top of his class at the Air Assault School at Fort Campbell. It's a 10-day course that is both physically and academically challenging, teaching soldiers the foundations of heliborne operations to include troop transportation, sling loaded cargo and equipment transportation, medical and casualty evacuation operations, and air assault operations.

Recommended Content:

Health Readiness & Combat Support

Could a Therapy Dog Help with Your Dental Anxiety?

Article
6/2/2022
Air Force Brig. Gen. Goldie, a facility therapy dog at Walter Reed National Military Medical Center, helps reduce anxiety in a patient with complex dental conditions that require multiple appointments. The use of therapy dogs is part of an ongoing study with these patients.

A first-of-its-kind study at Walter Reed National Military Medical Center is researching whether using facility therapy dogs in dentists’ offices could reduce patient anxiety and improve outcomes for military dental treatment programs.

Recommended Content:

Health Readiness & Combat Support | Total Force Fitness

Tips for Military Parents Planning PCS Moves with Children

Article
6/2/2022
Moving can be hard on military families, especially on children. Moving to a new home, going to a new school, finding new friends – it can be unsettling for kids of any age. Yet there are things that service members can do to prepare for a permanent change of station move that can make for a smoother transition for the children.

Moving can be hard on military families, especially on children. Moving to a new home, going to a new school, finding new friends – it can be unsettling for kids of any age. Yet, there are things that service members can do to prepare for a permanent change of station move that can make for a smoother transition for the children.

Recommended Content:

Health Readiness & Combat Support | Total Force Fitness

Corneal Collagen Cross Linking in the Military a Game Changer

Article
5/27/2022
Corneal collagen cross-linking, known as CXL, the first and only treatment to date that is proven to stop Keratoconus, KCN, progression.

Corneal collagen cross-linking, known as CXL, the first and only treatment to date that is proven to stop Keratoconus, KCN, progression.

Recommended Content:

Health Readiness & Combat Support
<< < 1 2 3 4 5  ... > >> 
Showing results 1 - 15 Page 1 of 6
Refine your search
Last Updated: August 10, 2022
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery